APA

Vearing C., Lee F., Wimmer-Kleikamp S., Spirkoska V., To C., Stylianou C., Spanevello M., Brechbiel M., Boyd A. W., Scott A. M. & Lackmann M. (20051004). Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. : Cancer research.

Chicago

Vearing Christopher, Lee Fook-Thean, Wimmer-Kleikamp Sabine, Spirkoska Violeta, To Catherine, Stylianou Con, Spanevello Mark, Brechbiel Martin, Boyd Andrew W, Scott Andrew M and Lackmann Martin. 20051004. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. : Cancer research.

Harvard

Vearing C., Lee F., Wimmer-Kleikamp S., Spirkoska V., To C., Stylianou C., Spanevello M., Brechbiel M., Boyd A. W., Scott A. M. and Lackmann M. (20051004). Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. : Cancer research.

MLA

Vearing Christopher, Lee Fook-Thean, Wimmer-Kleikamp Sabine, Spirkoska Violeta, To Catherine, Stylianou Con, Spanevello Mark, Brechbiel Martin, Boyd Andrew W, Scott Andrew M and Lackmann Martin. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. : Cancer research. 20051004.